Come up with a name for your new list and we'll add to it:
Histogen raised a round of funding on August 16, 2016. Investors include
Huapont Life Sciences.
Histogen is a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a bioreactor that mimics the embryonic environment. Histogen has developed a rich pro…